BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Annese V. A Review of Extraintestinal Manifestations and Complications of Inflammatory Bowel Disease. Saudi J Med Med Sci 2019;7:66-73. [PMID: 31080385 DOI: 10.4103/sjmms.sjmms_81_18] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Pytrus W, Akutko K, Pytrus T, Turno-Kręcicka A. A Review of Ophthalmic Complications in Inflammatory Bowel Diseases. J Clin Med 2022;11. [PMID: 36556071 DOI: 10.3390/jcm11247457] [Reference Citation Analysis]
2 Farraj KL, Pellegrini JR, Munshi RF, Russe‐russe J, Kaliounji A, Tiwana MS, Srivastava P, Subramani K. Chronic steroid use: An overlooked impact on patients with inflammatory bowel disease. JGH Open 2022;6:910-914. [DOI: 10.1002/jgh3.12841] [Reference Citation Analysis]
3 Nopwinyoow N, Chatuphonp W, Tatiya-aph N, Jarukamjor K. Garcinia mangostana and α-Mangostin Revive Ulcerative Colitis-Modified Hepatic Cytochrome P450 Profiles in Mice. Pakistan J of Biological Sciences 2022;25:843-51. [DOI: 10.3923/pjbs.2022.843.851] [Reference Citation Analysis]
4 Chen L, Jiao T, Liu W, Luo Y, Wang J, Guo X, Tong X, Lin Z, Sun C, Wang K, He Y, Zhang Y, Xu H, Wang J, Zuo J, Ding Q, He S, Gonzalez FJ, Xie C. Hepatic cytochrome P450 8B1 and cholic acid potentiate intestinal epithelial injury in colitis by suppressing intestinal stem cell renewal. Cell Stem Cell 2022;29:1366-1381.e9. [PMID: 36055192 DOI: 10.1016/j.stem.2022.08.008] [Reference Citation Analysis]
5 Cuny A, Guillo L, Baumann C, Netter P, Danese S, Caron B, Peyrin-biroulet L, Angioi K. Ocular Manifestations in Patients with Inflammatory Bowel Disease in the Biologics Era. JCM 2022;11:4538. [DOI: 10.3390/jcm11154538] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Caban M, Lewandowska U. Polyphenols and the potential mechanisms of their therapeutic benefits against inflammatory bowel diseases. Journal of Functional Foods 2022;95:105181. [DOI: 10.1016/j.jff.2022.105181] [Reference Citation Analysis]
7 Lin Y, Liu H, Bu L, Chen C, Ye X. Review of the Effects and Mechanism of Curcumin in the Treatment of Inflammatory Bowel Disease. Front Pharmacol 2022;13:908077. [DOI: 10.3389/fphar.2022.908077] [Reference Citation Analysis]
8 Tortora C, Di Paola A, Creoli M, Argenziano M, Martinelli M, Miele E, Rossi F, Strisciuglio C. Effects of CB2 and TRPV1 Stimulation on Osteoclast Overactivity Induced by Iron in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2022;28:1244-53. [PMID: 35472140 DOI: 10.1093/ibd/izac073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Pugliese N, Arcari I, Aghemo A, Lania AG, Lleo A, Mazziotti G. Osteosarcopenia in autoimmune cholestatic liver diseases: Causes, management, and challenges . World J Gastroenterol 2022; 28(14): 1430-1443 [DOI: 10.3748/wjg.v28.i14.1430] [Reference Citation Analysis]
10 Singh U, Singh B, Bellini MI. Immunosuppressive regimens and outcomes of inflammatory bowel disease patients requiring kidney transplantation. World J Transplant 2022; 12(2): 21-23 [DOI: 10.5500/wjt.v12.i2.21] [Reference Citation Analysis]
11 Xing F, Chiu KH, Yang J, Ye H, Zhang L, Liu C, Yuen KY. Pyoderma gangrenosum with pulmonary involvement: a pulmonary special report and literature review. Expert Rev Respir Med 2022. [PMID: 35034556 DOI: 10.1080/17476348.2022.2027756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Fedor I, Zold E, Barta Z. Temporal Relationship of Extraintestinal Manifestations in Inflammatory Bowel Disease. J Clin Med 2021;10:5984. [PMID: 34945280 DOI: 10.3390/jcm10245984] [Reference Citation Analysis]
13 Janardhana P, Al-Kadhi S. A review of ophthalmic manifestations of inflammatory bowel disease and associated treatments. Curr Opin Ophthalmol 2021;32:549-54. [PMID: 34506327 DOI: 10.1097/ICU.0000000000000808] [Reference Citation Analysis]
14 Lin TY, Lai YF, Chen PH, Chung CH, Chen CL, Chen YH, Chen JT, Kuo PC, Chien WC, Hsieh YH. Association Between Ischemic Optic Neuropathy and Inflammatory Bowel Disease: A Population-Based Cohort Study in Taiwan. Front Med (Lausanne) 2021;8:753367. [PMID: 34651004 DOI: 10.3389/fmed.2021.753367] [Reference Citation Analysis]
15 Cucinotta U, Romano C, Dipasquale V. Pancreatic Associated Manifestations in Pediatric Inflammatory Bowel Diseases. Genes (Basel) 2021;12:1372. [PMID: 34573354 DOI: 10.3390/genes12091372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Roth R, Vavricka S, Scharl M, Schreiner P, Safroneeva E, Greuter T, Zeitz J, Misselwitz B, Schoepfer A, Barry MP, Rogler G, Biedermann L; Swiss IBD cohort study. The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients. United European Gastroenterol J 2021. [PMID: 34431613 DOI: 10.1002/ueg2.12125] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
17 Woźniak M, Kurnatowska I, Małecka-Panas E, Talar-Wojnarowska R. Leukocytapheresis in patients with inflammatory bowel diseases. Prz Gastroenterol 2021;6:99-105. [PMID: 34276835 DOI: 10.5114/pg.2021.106658] [Reference Citation Analysis]
18 Rubin DT, Reinisch W, Greuter T, Kotze PG, Pinheiro M, Mundayat R, Maller E, Fellmann M, Lawendy N, Modesto I, Vavricka SR, Lichtenstein GR. Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis. Therap Adv Gastroenterol 2021;14:17562848211005708. [PMID: 34035832 DOI: 10.1177/17562848211005708] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
19 Hung YT, Le PH, Kuo CJ, Tang YC, Chiou MJ, Chiu CT, Kuo CF, Huang YH. The Temporal Relationships and Associations between Cutaneous Manifestations and Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study. J Clin Med 2021;10:1311. [PMID: 33810197 DOI: 10.3390/jcm10061311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Verma A, Rathi B, Sharda S. Machine Learning Based Risk Assessment and Early Diagnostic Model of Inflammatory Bowel Disease Associated Arthropathy. IOP Conf Ser : Mater Sci Eng 2021;1099:012017. [DOI: 10.1088/1757-899x/1099/1/012017] [Reference Citation Analysis]
21 Konidari A, Dickens D, Pirmohamed M. Inflammatory Bowel Disease: A Personalized Approach. Front Pediatr 2020;8:620545. [PMID: 33643966 DOI: 10.3389/fped.2020.620545] [Reference Citation Analysis]
22 Dvornikova KA, Bystrova EY, Churilov LP, Lerner A. Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection. Mol Biol Rep 2021;48:5745-58. [PMID: 34296352 DOI: 10.1007/s11033-021-06565-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
23 Lee SA. A Model of the Quality of Life in Patients with Crohn’s Disease. J Korean Acad Fundam Nurs 2020;27:333-343. [DOI: 10.7739/jkafn.2020.27.4.333] [Reference Citation Analysis]
24 Xin Z, Zhai Z, Long H, Zhang F, Ni X, Deng J, Yi L, Deng B. Metabolic Profiling by UPLC-Orbitrap-MS/MS of Liver from C57BL/6 Mice with DSS-Induced Inflammatory Bowel Disease. Mediators Inflamm 2020;2020:6020247. [PMID: 33029104 DOI: 10.1155/2020/6020247] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Keller R, Mazurak N, Fantasia L, Fusco S, Malek NP, Wehkamp J, Enck P, Klag T. Quality of life in inflammatory bowel diseases: it is not all about the bowel. Intest Res 2021;19:45-52. [PMID: 32093437 DOI: 10.5217/ir.2019.00135] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
26 Еxtraintestinal manifestations of inflammatory bowel disease. Actual problems of modern medicine 2020. [DOI: 10.26565/2617-409x-2020-5-08] [Reference Citation Analysis]
27 Almarri N, Alobaidli A, Almarhabi A, Alshammari M. Acute pancreatitis as an initial presentation of Crohn's disease: A case report. J Family Med Prim Care 2019;8:3752. [DOI: 10.4103/jfmpc.jfmpc_753_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]